Feasibility of overhauser-enhanced MR imaging with nitroxide free radicals

Journal of Magnetic Resonance Imaging

Volumn 6, Issue 1, 1996, Pages 261-263

  Lee, James N ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast agents; Electron spin resonance; Free radicals; Low field; Mammography; Overhauser

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FREE RADICAL; NITROGEN OXIDE; NITROXYL;

ARTICLE; FEASIBILITY STUDY; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIA; FEASIBILITY STUDIES; FREE RADICALS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; NITROGEN OXIDES;

EID: 0029682219     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880060147     Document Type: Article

References (15)

1. Lurie DJ, Hutchison JMS, Bell LH, Nicholson I, Bussell DM, Mallard JR. Field-cycled proton-electron double-resonance imaging of free radicals in large aqueous samples. J Magn Reson 1989; 84:431-437.
2. Grucker D. In vivo detection of injected free radicals by Overhauser effect imaging. Magn Reson Med 1990; 14:140-147.
3. Ehman RL, Wesbey GE, Moon KL, et al. Enhanced MRI of tumors utilizing a new nitroxyl spin label contrast agent. Magn Reson Imaging 1985; 3:89-97.
4. Schaefer DJ, Bioeffects of MRI and patient safety. In: Bronskill MJ, Sprawls P, eds. The physics of MRI. New York: American Institute of Physics, 1993; 607.
5. Roschmann P. Radiofrequency penetration and absorption in the human body: limitations to high-field whole-body nuclear magnetic resonance imaging. Med Phys 1987; 14:922-931.
6. Gilles R. Guinebretiere J, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 1993; 188:473-478.
7. 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? Med Phys 1987; 14:1-37.
8. Watson AD, Rocklage SM, Carvlin NJ. Contrast agents. In: Stark DD, Bradley WG Jr, eds. Magnetic resonance imaging. St. Louis: Mosby Year Book, 1992; 372.
9. Edelstein WA, Glover GH, Hardy CJ, Redington RW. The intrinsic signal-to-noise ratio in NMR imaging. Magn Reson Med 1986; 3:604-618.
10. Bottomley PA, Redington RW, Edelstein WA, Schenck JF. Estimating radiofrequency power deposition in body NMR imaging. Magn Reson Med 1985; 2:336-349.
11. Vallet P, Van Haverbeke Y, Bonnet PA, Subra G, Chapat J, Muller RN. Relaxivity enhancement of low molecular weight nitroxide stable free radicals: importance of structure and medium. Magn Reson Med 1994; 32:11-15.
12. Grucker D, Guiberteau T, Eclancher B, Chambron J, Chiarelli R, Rassat A. Dynamic nuclear polarization with nitroxides dissolved in biological fluids. In: Proceedings of the annual meeting of the Society of Magnetic Resonance in Medicine, New York, 1993. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1993; 107.
13. Nicholson I, Lurie DJ, Robb FJL. The application of proton-electron double-resonance imaging techniques to proton mobility studies. J Magn Reson B 1994; 104:250.
14. Leunbach I. Method of electron spin resonance enhanced magnetic resonance imaging. U.S. patent 4,984,573. issued Jan. 15, 1991, assigned to Hafslund Nycomed Innovation AB, Malvroe, Sweden.
15. Leunbach I. Magnetic resonance imaging. U.S. patent 5,231,354, issued July 27, 1993, assigned to Nycomed Innovation AB, Malmo, Sweden.